BioWorld Feb 6, 2026 Shenzhen Salubris Pharmaceuticals synthesizes dual PCSK9/HMG-CoA reductase inhibitors
Endpoints News Feb 6, 2026 Geoff McDonough's big plans for NodThera's NLRP3; Enhertu leader steps down at Daiichi
Endpoints News Feb 6, 2026 Roivant spinout Priovant touts Phase 2 brepocitinib data in cutaneous sarcoidosis
Lonza News Feb 6, 2026 Lonza Group (OTCMKTS:LZAGY) Rating Lowered to "Strong Sell" at Zacks Research - MarketBeat
Agilent Feb 6, 2026 Linscomb Wealth Inc. Invests $2.94 Million in Agilent Technologies, Inc. $A - MarketBeat
Endpoints News Feb 6, 2026 Illumina bets on healthcare after Trump administration's NIH funding disruptions
Illumina Feb 6, 2026 Illumina bets on healthcare customers after NIH funding disruptions - Endpoints News
Agilent Feb 6, 2026 PBSA Market Is Booming Worldwide With Agilent Technologies • Bio-Rad Laboratories • PerkinElmer • Illumina - openPR.com
Guangzhou JET Bio-Filtration Co., Ltd. Feb 6, 2026 Xanthatin Targets CISD1 to Drive Ferroptosis and Mitophagy as a Dual Anticancer Strategy in Triple-Negative Breast Cancer - Wiley